Posted: May 5, 2009

NanoVentures Australia COO To Be Key Speaker At Major US Biotechnology Conference in May

(Nanowerk News) Dr Bob Irving, Chief Operating Officer of NanoVentures Australia, is a key speaker at a major US Biotechnology conference in mid May.
Bob, well known for his leadership of therapeutic development based on nanoparticles, will present at the 3rd Annual Drug Delivery Summit, from the 14th to the 15th of May 2009 in San Francisco.
Bob Irving May 2009Bob will present on The Challenges of Delivering Large Molecule Therapeutics: Nanotechnology Enhancements for Transdermal and Pulmonary Delivery.
Prominent speakers at the Summit include leaders from Merck, Johnson & Johnson, NanoCyte, Altea, and Aerogen.
Source: NanoVentures Australia (press release)
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: